NPS Pharmaceuticals, Inc. (NASDAQ: NPSP) reported the receipt of Paragraph IV Certification Notice Letters related to certain drug manufacturers' Abbreviated ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE